B. Reid

发表

Live Multicellular Tumor Spheroid Models For High-Content Imaging and Screening In Cancer Drug Discovery

P. Kabos, C. Sartorius, Qiong Zhou, 2014, Current chemical genomics and translational medicine.

Chromophore formation in green fluorescent protein.

B. Reid, G. C. Flynn, B. Reid, 1997, Biochemistry.

Structural Basis for Inhibition of Protein-tyrosine Phosphatase 1B by Isothiazolidinone Heterocyclic Phosphonate Mimetics*

Michael Bower, Richard Wynn, Ronald Klabe, 2006, Journal of Biological Chemistry.

Structural basis for inhibition of protein-tyrosine phosphatase 1B by isothiazolidinone heterocyclic phosphonate mimetics.

Zelda R. Wasserman, Paul J. Ala, Ronald M. Klabe, 2006 .

ClpS, a substrate modulator of the ClpAP machine.

A. Horwich, B. Bukau, B. Reid, 2002, Molecular cell.

GroEL Binds to and Unfolds Rhodanese Posttranslationally (*)

G. C. Flynn, B. Reid, 1996, The Journal of Biological Chemistry.

A Small-Molecule Inhibitor of Hepatitis C Virus Infectivity

W. Zhong, Maria V. Pokrovskii, W. Delaney, 2013, Antimicrobial Agents and Chemotherapy.

Neoamphimedine Circumvents Metnase-Enhanced DNA Topoisomerase IIα Activity Through ATP-Competitive Inhibition

R. Hromas, J. Nickoloff, Qiong Zhou, 2011, Marine drugs.

The multicellular tumor spheroid model for high-throughput cancer drug discovery

Daniel V LaBarbera, Brian G Reid, Byong Hoon Yoo, 2012, Expert opinion on drug discovery.

Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics.

Karl Blom, Michael Bower, James Pruitt, 2005, Journal of medicinal chemistry.

Discovery of novel small molecule inhibitors of cardiac hypertrophy using high throughput, high content imaging.

T. McKinsey, M. Cavasin, B. Reid, 2016, Journal of molecular and cellular cardiology.

High-Throughput Determination of Mode of Inhibition in Lead Identification and Optimization

Min Wei, Richard Wynn, Gregory Hollis, 2007, Journal of biomolecular screening.

Active Metabolite of Aeruginascin (4-Hydroxy-N,N,N-trimethyltryptamine): Synthesis, Structure, and Serotonergic Binding Affinity

David R. Manke, B. Reid, J. Golen, 2020, ACS omega.

Global unfolding of a substrate protein by the Hsp100 chaperone ClpA

A. Horwich, A. Miranker, B. Reid, 1999, Nature.

Screening and Identification of a Novel Class of TGF-β Type 1 Receptor Kinase Inhibitor

Xiaohong Liu, S. Wise, K. Pitts, 2011, Journal of biomolecular screening.

ClpA mediates directional translocation of substrate proteins into the ClpP protease

A. Horwich, W. Fenton, B. Reid, 2001, Proceedings of the National Academy of Sciences of the United States of America.

DNA primase. Processivity and the primase to polymerase alpha activity switch.

R. Kuchta, B. Reid, L. Chang, 1990, The Journal of biological chemistry.

BET acetyl-lysine binding proteins control pathological cardiac hypertrophy.

J. Qi, J. Bradner, T. McKinsey, 2013, Journal of molecular and cellular cardiology.

Roles of the N-domains of the ClpA Unfoldase in Binding Substrate Proteins and in Stable Complex Formation with the ClpP Protease*

A. Horwich, W. Fenton, B. Reid, 2005, Journal of Biological Chemistry.

Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy

B. Harrison, T. McKinsey, M. Wempe, 2013, Proceedings of the National Academy of Sciences.

Suppression of HDAC nuclear export and cardiomyocyte hypertrophy by novel irreversible inhibitors of CRM1.

Thierry Mann, Jinhai Gao, Yan Feng, 2009, Biochimica et biophysica acta.

A High-Content Assay to Identify Small-Molecule Modulators of a Cancer Stem Cell Population in Luminal Breast Cancer

P. Kabos, C. Sartorius, J. Schaack, 2012, Journal of biomolecular screening.

A Small-Molecule Inhibitor of Hepatitis C Virus Infectivity

W. Zhong, Maria V. Pokrovskii, W. Delaney, 2013, Antimicrobial Agents and Chemotherapy.